Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Gustavsen, Marte Wendel ^a,b   Page, Christian Magnus ^a,b   Moen, Stine Marit ^a   Bjølgerud, Anja ^a,b   Berg Hansen, Pål ^a,b   Nygaard, Gro O ^a,b   Sandvik, Leiv ^a,b   Lie, Benedicte A ^c   Celius, Elisabeth G ^a   Harbo, Hanne F ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

15:01; Environmental risk factors; HLA DRB1; Hygiene hypothesis; Mononucleosis; Multiple sclerosis; Tobacco use

Indexed keywords

HLA DRB1 ANTIGEN;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CAT; CHILDHOOD; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOG; DOMESTIC ANIMAL; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HETEROZYGOTE; HUMAN; HYGIENE HYPOTHESIS; IMMUNOGENETICS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MONONUCLEOSIS; MULTIPLE SCLEROSIS; NORWEGIAN (CITIZEN); QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKELESS TOBACCO; SMOKING; TOBACCO USE; VACCINATION; ANIMAL; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; NORWAY; PET ANIMAL; RISK; YOUNG ADULT;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CATS; DOGS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFECTIOUS MONONUCLEOSIS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; ODDS RATIO; PETS; QUESTIONNAIRES; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84908094411     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-014-0196-x     Document Type: Article

References (46)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
2. Ascherio A, Munger KL, Lunemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012, 8:602-612. 10.1038/nrneurol.2012.198, 23045241.
3. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 2012, 248:87-103. 10.1111/j.1600-065X.2012.01134.x, 22725956.
4. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. 10.1038/nature10251.
5. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013, 45:1353-1360. 10.1038/ng.2770.
6. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009, 73:696-701. 10.1212/WNL.0b013e3181b59c40, 19720976.
7. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler 2013, 19:1009-1013. 10.1177/1352458512471879, 23319071.
8. Hedstrom A, Baarnhielm M, Olsson T, Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler 2011, 17:788-793. 10.1177/1352458511399610, 21372120.
9. Hedstrom AK, Sundqvist E, Baarnhielm M, Nordin N, Hillert J, Kockum I, Olsson T, Alfredsson L. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 2011, 134:653-664. 10.1093/brain/awq371, 21303861.
10. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000, 343:481-492. 10.1056/NEJM200008173430707, 10944566.
11. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006, 59:499-503. 10.1002/ana.20820, 16502434.
12. Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 2012, 13:14-20. 10.1038/gene.2011.42, 21776012.
13. Sundstrom P, Nystrom M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis. J Neuroimmunol 2009, 215:102-107. 10.1016/j.jneuroim.2009.08.004, 19733917.
14. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010, 9:520-532. 10.1016/S1474-4422(10)70064-8, 20398859.
15. Holmqvist P, Hammar M, Landtblom AM, Brynhildsen J. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 2010, 94:2835-2837. 10.1016/j.fertnstert.2010.06.045, 20807659.
16. Disanto G, Handel AE, Ramagopalan SV. Estrogen-vitamin D interaction in multiple sclerosis. Fertil Steril 2011, 95:e3. author reply e4, 10.1016/j.fertnstert.2010.09.047, 21055742.
17. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260. 10.1136/bmj.299.6710.1259, 2513902.
18. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. II: multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966, 29:60-68. 10.1136/jnnp.29.1.60, 5910580.
19. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007, 61:97-108. 10.1002/ana.21067, 17230481.
20. Esch KJ, Petersen CA. Transmission and epidemiology of zoonotic protozoal diseases of companion animals. Clin Microbiol Rev 2013, 26:58-85. 10.1128/CMR.00067-12, 23297259.
21. Heinrich J, Gehring U, Douwes J, Koch A, Fahlbusch B, Bischof W, Wichmann HE. Pets and vermin are associated with high endotoxin levels in house dust. Clin Exp Allergy 2001, 31:1839-1845. 10.1046/j.1365-2222.2001.01220.x, 11737034.
22. Cook SD, Dowling PC. A possible association between house pets and multiple sclerosis. Lancet 1977, 1:980-982. 10.1016/S0140-6736(77)92281-4, 67471.
23. Bansil S, Singhal BS, Ahuja GK, Riise T, Ladiwala U, Behari M, Cook SD. Multiple sclerosis in India: a case-control study of environmental exposures. Acta Neurol Scand 1997, 95:90-95. 10.1111/j.1600-0404.1997.tb00075.x, 9059727.
24. Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 2001, 92:281-285. 11965642.
25. Alonso A, Cook SD, Maghzi AH, Divani AA. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011, 17:550-555. 10.1177/1352458510397685, 21325015.
26. Conradi S, Malzahn U, Schroter F, Paul F, Quill S, Spruth E, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B. Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol 2011, 11:123. 10.1186/1471-2377-11-123, 21978074.
27. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231. 10.1002/ana.410130302, 6847134.
28. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302. 10.1002/ana.22366, 21387374.
29. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001, 8:463-469. 10.1046/j.1468-1331.2001.00269.x, 11554910.
30. Maniaol AH, Brunborg C, Tallaksen CM. Development and validation of a self-administered questionnaire for myasthenia gravis patients. Neuroepidemiology 2010, 34:253-261. 10.1159/000297753, 20299807.
31. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, Bratberg G, Heggland J, Holmen J. Cohort profile: the HUNT study, Norway. Int J Epidemiol 2013, 42:968-977. 10.1093/ije/dys095, 22879362.
32. Sayer DC, Whidborne R, De SD, Rozemuller EH, Christiansen FT, Tilanus MG. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens 2004, 63:412-423. 10.1111/j.0001-2815.2004.00214.x, 15104673.
33. Dilthey A, Leslie S, Moutsianas L, Shen J, Cox C, Nelson MR, McVean G. Multi-population classical HLA type imputation. PLoS Comput Biol 2013, 9:e1002877. 10.1371/journal.pcbi.1002877, 23459081.
34. Smoking habits. 2012, http://www.ssb.no/en/helse/statistikker/royk/aar/2014-02-05
35. D'Hooghe MB, D'Hooghe T, De Keyser J. Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosis. Gynecol Obstet Invest 2013, 75:73-84. 10.1159/000346319, 23343711.
36. Ramagopalan SV, Valdar W, Criscuoli M, DeLuca GC, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick AD. Age of puberty and the risk of multiple sclerosis: a population based study. Eur J Neurol 2009, 16:342-347. 10.1111/j.1468-1331.2008.02431.x, 19170744.
37. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995, 118(Pt 1):253-261. 10.1093/brain/118.1.253, 7895009.
38. Ponsonby AL, Lucas RM, van der Mei IA, Dear K, Valery PC, Pender MP, Taylor BV, Kilpatrick TJ, Coulthard A, Chapman C, Williams D, McMichael AJ, Dwyer T. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 2012, 78:867-874. 10.1212/WNL.0b013e31824c4648, 22402857.
39. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55:848-854. 10.1212/WNL.55.6.848, 10994007.
40. Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R, Revelli A. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci 2006, 27:231-239. 10.1007/s10072-006-0676-x, 16998725.
41. Lunny C, Knopp-Sihota JA, Fraser SN. Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies. BMC Neurol 2013, 13:41. 10.1186/1471-2377-13-41, 23648120.
42. Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 2010, 16:855-861. 10.1177/1352458510369146, 20463037.
43. Carter CJ. Toxoplasmosis and polygenic disease susceptibility genes: extensive toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Pathog 2013, 2013:965046. 10.1155/2013/965046, 23533776.
44. Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by toxoplasma gondii. Nat Rev Immunol 2005, 5:162-170. 10.1038/nri1547, 15662369.
45. Bager P, Nielsen NM, Bihrmann K, Frisch M, Hjalgrim H, Wohlfart J, Koch-Henriksen N, Melbye M, Westergaard T. Childhood infections and risk of multiple sclerosis. Brain 2004, 127:2491-2497. 10.1093/brain/awh283, 15371288.
46. Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 2011, 258:1197-1206. 10.1007/s00415-011-5984-2, 21431896.